Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01284218Completed

Retrospective Database Study of Real World Abilify Outcomes in Major Depressive Disorder (MDD)

Role: collaborator

NCT00842855Completed

Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France

Role: collaborator

NCT00795093Completed

Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US

Role: collaborator

NCT00698165Completed

Observational Study on Costs and Caregiver Burden in Alzheimer's Disease

Role: collaborator

All 4 trials loaded